0.30p+0.01 (+4.71%)21 Nov 2024, 16:22
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Aptamer Group PLC Fundamentals

Company NameAptamer Group PLCLast Updated2024-11-21
IndustryBiotechnologySectorHealthcare
Shares in Issue1.920 bnMarket Cap£5.93 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.01EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.2951Debt Equity Ratio0.6359
Asset Equity Ratio3.1218Cash Equity Ratio0.9808
Quick Ratio0.8961Current Ratio1.27
Price To Book Value6.3857ROCE0

Aptamer Group PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Aptamer Group PLC Company Financials

Assets2024202320222021
Tangible Assets£611,000.00£721,000.00£1.82 m£519,000.00
Intangible Assets£165,000.00£70,000.00£341,000.00£222,000.00
Investments0000
Total Fixed Assets£1.15 m£1.16 m£2.54 m£741,000.00
Stocks£119,000.00£204,000.00£420,000.00£90,000.00
Debtors£277,000.00£501,000.00£1.15 m£266,000.00
Cash & Equivalents£870,000.00£234,000.00£6.69 m£369,000.00
Other Assets0000
Total Assets£2.77 m£2.75 m£11.52 m£2.06 m
Liabilities2024202320222021
Creditors within 1 year£1.28 m£1.64 m£2.37 m£1.86 m
Creditors after 1 year£602,000.00£806,000.00£1.09 m£94,000.00
Other Liabilities0000
Total Liabilities£1.88 m£2.45 m£3.47 m£1.96 m
Net assets£887,000.00£304,000.00£8.05 m£105,000.00
Equity2024202320222021
Called up share capital£467,000.00£69,000.00£69,000.00£30,000.00
Share Premium£12.67 m£9.58 m£9.57 m£5.20 m
Profit / Loss-£3.14 m-£8.30 m-£2.64 m-£2.91 m
Other Equity£887,000.00£304,000.00£8.05 m£105,000.00
Preference & Minorities0000
Total Capital Employed£887,000.00£304,000.00£8.05 m£105,000.00
Ratios2024202320222021
Debt Ratio£0.39£0.72£0.120
Debt-to-Equity£0.64£2.51£0.130
Assets / Equity3.12183.12183.12183.1218
Cash / Equity0.98080.98080.98080.9808
EPS-£0.01-£0.11-£0.03-£0.03
Cash Flow2024202320222021
Cash from operating activities-£2.28 m-£4.06 m-£2.38 m-£1.37 m
Cashflow before financing£758,000.00-£4.43 m£6.74 m£500,000.00
Increase in Cash£636,000.00-£6.46 m£6.32 m£76,000.00
Income2024202320222021
Turnover£860,000.00£1.75 m£4.04 m£1.60 m
Cost of sales£610,000.00£1.39 m£1.35 m£927,000.00
Gross Profit£250,000.00£359,000.00£2.69 m£673,000.00
Operating Profit-£3.08 m-£8.16 m-£2.58 m-£2.87 m
Pre-Tax profit-£3.14 m-£8.30 m-£2.64 m-£2.91 m

Aptamer Group PLC Company Background

SectorHealthcare
ActivitiesAptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics.
Latest Interim Date28 Mar 2024
Latest Fiscal Year End Date22 Oct 2024

Aptamer Group PLC Directors

AppointedNamePosition
2024-08-13Mr. Stephen HullExecutive Director,Chairman
2023-11-21Dr. Ian David GilhamExecutive Director,Chairman
2024-08-13Mr. Dean Andrew FieldingNon-Executive Director
2024-08-14Dr. Arron Craig TolleyExecutive Director,Chief Executive Officer
2024-11-05Dr. David Harry John BunkaExecutive Director,Chief Scientific Officer
2022-06-13Ms. Eleanor Margaret BrownExecutive Director,Chief Financial Officer and Company Secretary
2024-11-05Dr. Adam HargreavesNon-Executive Director,Chairman
2024-08-14Mr. Andrew RapsonExecutive Director,Chief Financial Officer and Company Secretary

Aptamer Group PLC Contact Details

Company NameAptamer Group PLC
AddressBio Centre, Innovation Way, Second Floor, Heslington, York, YO10 5NY
Telephone+44 1904567790
Websitehttps://www.aptamergroup.com

Aptamer Group PLC Advisors